Natesto Testosterone Nasal Gel- Acerus Predictions

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

 

[madman]

Peak levels drive efficacy

Trough levels maintain endogenous function and improve adverse events

 

[TLawyer]

So I guess you'd have to time your blood test to see your peak about an hour after taking it?

 

[madman]

So I guess you'd have to time your blood test to see your peak about an hour after taking it?

Most definitely.

Tmax approx. 40 min

Nasal administration of T (4.5% testosterone nasal gel, Natesto) allows for rapid absorption through the nasal mucosa such that serum T levels reach a peak concentration in ∼40 min.

 

[madman]

5:04-5:34

To view this content we will need your consent to set third party cookies.
For more detailed information, see our cookies page.

Accept third party cookies

Acerus Pharmaceuticals Corporation - Home

www.aceruspharma.com

OUR COMPANY​

Acerus is a Canadian-based pharmaceutical company focused on the commercialization and development of innovative pharmaceutical products that improve the patient experience.

Founded in 2008, Acerus has grown into a fully integrated specialty pharmaceutical company with expertise in all stages of the pharmaceutical product life-cycle. The company is focused on Men’s Health (Urology and Andrology).

Acerus’ foundational product Is NATESTO®, a testosterone therapy based on our patented nasal gel technology. NATESTO® is approved in the United States, Canada, and South Korea for the treatment of adult males diagnosed with hypogonadism.

Acerus operates from a Mississauga-based office and is listed on the Toronto Stock Exchange (TSX: ASP) and the OTCQB Exchange (OTCQB: ASPCF).